The 2nd Annual Kymanox Showcase, powered by Seed2Table Life Science, will take place on Wednesday, April 15, 2026, at the luxurious Umstead Hotel and Spa in Cary, North Carolina. Hosted by Kymanox Co-Founders Stephen M. Perry and Sarah J. Perry, this invitation-only evening is intentionally built differently – a private gathering that connects high-potential life science startups with sophisticated investors through meaningful, conversation-driven dialogue rather than traditional pitches.
Seed2Table, founded in North Carolina in 2023, is a national series of high-touch, invitation-only events that bring vetted early-stage companies together with active capital allocators across life sciences and other high-impact sectors. By creating intimate, curated experiences, Seed2Table helps founders secure their “seat at the table” with investors who can fuel real growth.
The inaugural 2025 Kymanox Hyper-Virtual Showcase delivered tremendous success. Held at the same prestigious venue, the event featured twelve carefully selected life science companies presented in an engaging, interview-style format that fostered thoughtful discussion and lasting connections. Attendees highlighted the exceptional quality of the presenting teams, the refined curation, and the productive networking in a low-pressure environment designed for real impact. The investor room was particularly strong, with confirmed participation from leading names including QHP Capital, Pappas Capital, Hatteras Capital Advisors, RED DOOR PROPERTY VENTURES LIMITED, Mangrove Ventures, Merck, Cape Fear Ventures, Second Foundation (2ndF), Robinson Ventures, LLC, Síol Venture Capital, RTP Capital Associates, and many more key players actively deploying capital in life sciences.
Building on that strong momentum, the 2026 program elevates the experience even further. While a few standout companies return for a second year to share their continued progress, the majority of this year’s presenters are new and exceptionally well-refined startups. The carefully curated lineup spans critical areas such as drug delivery, biologics, regenerative medicine, metabolic disease, autoimmunity, and patient safety – all chosen for their credible science, experienced leadership, and clear potential to address significant unmet patient needs.
Kymanox’s expertise in accelerating modern medicine development shines through in the event’s design. By leveraging their deep operational, regulatory, and engineering insight, the Showcase creates an environment where innovation can connect meaningfully with the capital and expertise needed to move faster and de-risk effectively. As one organizer noted, “This evening offers a curated experience to create meaningful discussions with people who understand what it takes to scale.”
The agenda prioritizes quality engagement and relationship-building:
- 4:30–5:30 pm: Networking with hors d’oeuvres and drinks
- 5:30–6:15 pm: Showcase Dialogues (Part 1)
- 6:15–6:45 pm: Refreshment break
- 6:45–7:30 pm: Showcase Dialogues (Part 2)
- 7:30–10:00 pm: Dinner and continued networking
Business semi-formal to business casual attire is requested. Space is intentionally limited to preserve the intimate, high-quality atmosphere that made last year so effective — ensuring the right founders meet the right funders in a setting that drives real conversations and potential collaboration.
In an industry facing ongoing funding, regulatory, and development challenges, the Kymanox Showcase stands out as a catalyst that bridges promising innovation with strategic capital and operational know-how. With last year’s proven track record and this year’s fresh, elevated lineup, the 2nd Annual event is poised to deliver even greater impact for patients and the life sciences ecosystem.
For more information or to request an investor or founder invitation, visit: https://luma.com/5g4958h3.
